SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+2.2%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.84B
AUM Growth
-$136M
(-4.5%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-5.06%
Top 10 Holdings %
Top 10 Hldgs %
32.15%
Holding
473
New
70
Increased
58
Reduced
178
Closed
96
Top Buys
| 1 |
Burlington
BURL
|
$43.2M |
| 2 |
L3Harris
LHX
|
$37M |
| 3 |
Amgen
AMGN
|
$32.2M |
| 4 |
Delta Air Lines
DAL
|
$26.3M |
| 5 |
Keysight
KEYS
|
$25.4M |
Top Sells
| 1 |
TripAdvisor
TRIP
|
$48M |
| 2 |
Norfolk Southern
NSC
|
$32.6M |
| 3 |
Advance Auto Parts
AAP
|
$32.1M |
| 4 |
Adobe
ADBE
|
$30.6M |
| 5 |
NetApp
NTAP
|
$29.6M |
Sector Composition
| 1 | Technology | 33.08% |
| 2 | Healthcare | 13.95% |
| 3 | Consumer Discretionary | 12.73% |
| 4 | Communication Services | 11.1% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Iovance Biotherapeutics
IOVA
$901M
| $76K | ﹤0.01% |
+4,190
| New | +$76K |
|
252
PTC Therapeutics
PTCT
$4.55B
| $74K | ﹤0.01% |
2,200
+740
| +51% | +$24.9K |
|
|
MRTX
253
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $74K | ﹤0.01% |
+950
| New | +$74K |
|
|
IMMU
254
DELISTED
Immunomedics Inc
IMMU
| $74K | ﹤0.01% |
5,560
+1,690
| +44% | +$22.5K |
|
255
Natera
NTRA
$23.1B
| $72K | ﹤0.01% |
+2,200
| New | +$72K |
|
256
Silicom
SILC
$95.3M
| $72K | ﹤0.01% |
+2,270
| New | +$72K |
|
|
ICPT
257
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $70K | ﹤0.01% |
1,050
+420
| +67% | +$28K |
|
258
JPMorgan Chase
JPM
$809B
| $69K | ﹤0.01% |
584
-9,896
| -94% | -$1.17M |
|
259
SunCoke Energy
SXC
$667M
| $67K | ﹤0.01% |
11,957
| – | – |
|
|
NVTA
260
DELISTED
Invitae Corporation
NVTA
| $67K | ﹤0.01% |
+3,460
| New | +$67K |
|
|
ARNA
261
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $67K | ﹤0.01% |
1,470
+300
| +26% | +$13.7K |
|
262
Amicus Therapeutics
FOLD
$2.46B
| $66K | ﹤0.01% |
8,280
+3,320
| +67% | +$26.5K |
|
263
Quanex
NX
$836M
| $66K | ﹤0.01% |
3,650
| – | – |
|
|
RDUS
264
DELISTED
Radius Recycling
RDUS
| $64K | ﹤0.01% |
3,120
| – | – |
|
|
RDS.B
265
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $64K | ﹤0.01% |
1,062
-241
| -18% | -$14.5K |
|
|
GHDX
266
DELISTED
Genomic Health, Inc.
GHDX
| $64K | ﹤0.01% |
+950
| New | +$64K |
|
267
Shoe Carnival
SCVL
$673M
| $63K | ﹤0.01% |
3,860
| – | – |
|
268
TotalEnergies
TTE
$133B
| $63K | ﹤0.01% |
1,206
-644
| -35% | -$33.6K |
|
269
Wells Fargo
WFC
$253B
| $61K | ﹤0.01% |
1,200
-90
| -7% | -$4.58K |
|
270
PetMed Express
PETS
$63M
| $60K | ﹤0.01% |
3,310
| – | – |
|
271
Xencor
XNCR
$610M
| $60K | ﹤0.01% |
+1,780
| New | +$60K |
|
272
Citigroup
C
$176B
| $59K | ﹤0.01% |
850
-80
| -9% | -$5.55K |
|
273
Insmed
INSM
$30.7B
| $56K | ﹤0.01% |
3,150
+840
| +36% | +$14.9K |
|
|
XLRN
274
DELISTED
Acceleron Pharma Inc.
XLRN
| $54K | ﹤0.01% |
1,370
+530
| +63% | +$20.9K |
|
275
Heron Therapeutics
HRTX
$201M
| $53K | ﹤0.01% |
2,840
+530
| +23% | +$9.89K |
|